A therapeutic approach to perianal extramammary Paget's disease: Topical imiquimod can be useful to prevent or defer surgery

Medical Science Monitor

Volumn 13, Issue 6, 2007, Pages

  Vereecken, Pierre ^a,b,c,d,e   Awada, Ahmad ^c   Ghanem, Ghanem ^d   Da Costa, Claudia Marques ^a   Larsimont, Denis ^c   Simoens, Christian ^a   Da Costa, Pierre Mendes ^a   Hendlisz, Alain ^c  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c JULES BORDET INSTITUTE   (Belgium)

^d Laboratory of Experimental Surgery   (Belgium)

^e CHU Brugmann ^*  (Belgium)

Author keywords

Extramammary Paget's disease; Imiquimod; Immunotherapy; Skin cancer

Indexed keywords

IMIQUIMOD;

AGED; ARTICLE; CARCINOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EPIDERMIS; HUMAN; MALE; PAGET SKIN DISEASE; RECTUM ABDOMINOPERINEAL RESECTION; REMISSION; SKIN BIOPSY; SKIN DISEASE; SKIN IRRITATION; TREATMENT OUTCOME; TREATMENT REFUSAL;

ADMINISTRATION, TOPICAL; AGED; AMINOQUINOLINES; ANAL CANAL; ANTINEOPLASTIC AGENTS; HUMANS; MALE; PAGET'S DISEASE, EXTRAMAMMARY; SKIN NEOPLASMS;

EID: 34249800927     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Heymann WR: Extramammary Paget's disease. Clin Dermatol, 1993; 11: 83-87
2. Navi D, Huntley A: Imiquimod 5 percent cream and the treatment of cutaneous malignancy. Dermatol Online J, 2004; 10(1): 4
3. Villa AM, Berman B: Immunomodulators for skin cancer. J Drugs Dermatol, 2004; 3(5): 533-39
4. Stockfleth E, Trefzer U, Garcia-Bartels C et al: The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview. Br J Dermatol, 2003; 149(Suppl.66): 53-56
5. Berman B, Poochareon VN, Villa AM: Novel dermatologic uses of the immune response modifier imiquimod 5% cream. Skin Therapy Lett, 2002; 7(9): 1-6
6. Mirer E, El Sayed F, Ammoury A et al: Treatment of mammary and extrammamary Paget's skin disease with topical imiquimod. J Dermatol Treat, 2006; 17(3): 167-71
7. Delaunoit T, Neczyporenko F, Duttmann R et al: Perianal Paget's disease: case-report and review of the literature. Acta Gastroenterol Belg, 2004; 67: 228-31
8. Jabbar ASA: Perianal extramammary Paget's disease. Eur J Surg Oncol, 2000; 26: 612-14
9. Gupta AK, Cherman AM, Tyring SK: Viral and nonviral uses of imiquimod: a review. J Cutan Med Surg, 2004; 8(5): 338-52
10. Meyer T, Nindl I, Schmook T et al: Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures. Br J Dermatol, 2003; 149(Suppl.66): 9-13
11. Schön M, Bong AB, Drewniok C et al: Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Cancer Inst, 2003; 95: 1138-49
12. Badgwell C, Rosen T: Treatment of limited extent extramammary Paget's disease with 5 percent imiquimod cream. Dermatol Online J, 2006; 12(1): 22
13. Cohen PR, Schulze KE, Tschen JA et al: Treatment of extramammary Paget disease with topical imiquimod cream: case report and literature review. South Med J, 2006; 99(4): 396-402
14. Qian Z, Zeitoun NC, Shieh S et al: Successful treatment of extramammary Paget's disease with imiquimod. J Drugs Dermatol, 2003; 2(1): 73-76
15. Zampogna JC, Flowers FP, Roth WI, Hassenein AM: Treatment of primary limited cutaneous extramammary Paget's disease with topical imiquimod monotherapy: two cases reports. J Am Acad Dermatol, 2002; 47(Suppl.4): s229-35
16. Wang LC, Blanchard A, Judge DE et al: Successful treatment of recurrent extramammary Paget's disease of the vulva with topical imiquimod 5% cream. J Am Acad Dermatol, 2003; 49(4): 769-72
17. Ye JN, Rhew DC, Yip F, Edelstein L: Extramammary Paget's disease resistant to surgery and imiquimod monotherapy but responsive to imiquimod combination topical chemotherapy with 5-fluorouracil and retinoic acid: a case report. Cutis, 2006; 77(4): 245-50
18. Berman B, Spencer J, Villa A et al: Successful treatment of extrammamary Paget's disease of the scrotum with imiquimod 5% cream. Clin Exp Dermatol, 2003; 28(Suppl.1): 36-38